These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16252067)

  • 1. Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp).
    Schmitt U; Abou El-Ela A; Guo LJ; Glavinas H; Krajcsi P; Baron JM; Tillmann C; Hiemke C; Langguth P; Härtter S
    J Neural Transm (Vienna); 2006 Jul; 113(7):787-801. PubMed ID: 16252067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.
    El Ela AA; Härtter S; Schmitt U; Hiemke C; Spahn-Langguth H; Langguth P
    J Pharm Pharmacol; 2004 Aug; 56(8):967-75. PubMed ID: 15285840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.
    Liow JS; Lu S; McCarron JA; Hong J; Musachio JL; Pike VW; Innis RB; Zoghbi SS
    Synapse; 2007 Feb; 61(2):96-105. PubMed ID: 17117422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of enantiomers of sultopride in a human, rats and rabbits.
    Kamizono A; Inotsume N; Fukushima S; Nakano M
    Biol Pharm Bull; 1993 Nov; 16(11):1121-3. PubMed ID: 7906175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
    Hsiao P; Bui T; Ho RJ; Unadkat JD
    Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography.
    Sasongko L; Link JM; Muzi M; Mankoff DA; Yang X; Collier AC; Shoner SC; Unadkat JD
    Clin Pharmacol Ther; 2005 Jun; 77(6):503-14. PubMed ID: 15961982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB; Linnet K
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
    Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
    Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
    Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
    Syvänen S; Blomquist G; Sprycha M; Höglund AU; Roman M; Eriksson O; Hammarlund-Udenaes M; Långström B; Bergström M
    Neuroimage; 2006 Sep; 32(3):1134-41. PubMed ID: 16857389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.
    Damont A; Goutal S; Auvity S; Valette H; Kuhnast B; Saba W; Tournier N
    Eur J Pharm Sci; 2016 Aug; 91():98-104. PubMed ID: 27283486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prandial effect on the systemic exposure of amisulpride.
    Jang YJ; Jeong TC; Noh K; Baek IW; Kwon KI; Kim E; Yoon YR; Kang W
    Arch Pharm Res; 2014 Oct; 37(10):1325-8. PubMed ID: 24469600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.
    Dos Santos Pereira JN; Tadjerpisheh S; Abu Abed M; Saadatmand AR; Weksler B; Romero IA; Couraud PO; Brockmöller J; Tzvetkov MV
    AAPS J; 2014 Nov; 16(6):1247-58. PubMed ID: 25155823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the inhibition of intestinal P-glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeys.
    Tsukimoto M; Ohashi R; Torimoto N; Togo Y; Suzuki T; Maeda T; Kagawa Y
    Biopharm Drug Dispos; 2015 Jan; 36(1):15-33. PubMed ID: 25264342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study.
    Tsai PL; Tsai TH
    Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in in vitro cell experiments.
    Yang ZH; Sun X; Qi Y; Mei C; Sun XB; Du GH
    J Asian Nat Prod Res; 2012; 14(1):14-21. PubMed ID: 22263589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.